Characterization of Multi-dose RVX000222 in Combination With Statin Treatment in Dyslipidemia
Clinical trial NCT01863225 · TERMINATED
Trial details
- NCT number
- NCT01863225
- Sponsor
- Resverlogix Corp
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2013-06-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.